HIMS & HERS HEALTH INC's ticker is HIMS and the CUSIP is 433000106. A total of 141 filers reported holding HIMS & HERS HEALTH INC in Q4 2021. The put-call ratio across all filers is 1.04 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $45,054,429 | +66.7% | 2,231,522 | +27.8% | 0.01% | +60.0% |
| Q1 2024 | $27,022,192 | +148.2% | 1,746,748 | +42.8% | 0.01% | +150.0% |
| Q4 2023 | $10,885,484 | -29.5% | 1,223,088 | -50.2% | 0.00% | -33.3% |
| Q3 2023 | $15,433,704 | -23.3% | 2,453,689 | +14.6% | 0.00% | -25.0% |
| Q2 2023 | $20,131,661 | +36.5% | 2,141,666 | +44.1% | 0.00% | +33.3% |
| Q1 2023 | $14,744,939 | +238.6% | 1,486,385 | +118.8% | 0.00% | +200.0% |
| Q4 2022 | $4,354,678 | +365532.1% | 679,357 | +218.3% | 0.00% | – |
| Q3 2022 | $1,191 | +301.0% | 213,428 | +225.4% | 0.00% | – |
| Q2 2022 | $297 | -100.0% | 65,593 | -47.5% | 0.00% | – |
| Q1 2022 | $666,000 | -16.8% | 124,902 | +2.2% | 0.00% | – |
| Q4 2021 | $800,000 | -89.1% | 122,213 | -87.5% | 0.00% | -100.0% |
| Q3 2021 | $7,348,000 | +1209.8% | 974,544 | +1793.2% | 0.00% | – |
| Q2 2021 | $561,000 | -72.8% | 51,475 | -67.0% | 0.00% | -100.0% |
| Q1 2021 | $2,065,000 | – | 156,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NewView Capital Partners I, LLC | 3,935,444 | $36,993,174 | 32.47% |
| Institutional Venture Management XV, LLC | 7,709,729 | $72,471,453 | 28.51% |
| Foresite Capital Management V, LLC | 3,733,381 | $35,093,781 | 25.63% |
| Institutional Venture Management XVI, LLC | 7,709,740 | $72,471,556 | 22.39% |
| Redpoint Management, LLC | 7,577,016 | $71,223,950 | 11.11% |
| Metavasi Capital LP | 560,000 | $5,264,000 | 3.43% |
| MCKINLEY CAPITAL MANAGEMENT LLC | 683,144 | $6,421,553 | 0.86% |
| SAMLYN CAPITAL, LLC | 4,864,957 | $45,730,596 | 0.77% |
| Blue Investment Partners LLC | 94,614 | $889,372 | 0.68% |
| HAP Trading, LLC | 235,484 | $2,213,550 | 0.39% |